Thalidomide

THALOMID®

Overview

Thalidomide (Thalomid) is an immunomodulatory drug used in the treatment of multiple myeloma.

SparkCures ID 6
Developed By Celgene Corporation, a wholly owned subsidiary of Bristol Myers Squibb
Brand Name Thalomid®
Generic Name Thalidomide
Treatment Classifications

Clinical Trials

All Clinical Trials

View all active clinical trials around the US.

Untreated / Newly Diagnosed Multiple Myeloma

The following is a listing of clinical trials for patients with multiple myeloma who have been newly diagnosed or have not yet received treatment.

Verified
Daratumumab-Based Therapy for the Treatment of Newly Diagnosed Multiple Myeloma With Kidney Failure
View Trial

SparkCures Verified Accurate, up-to-date information. Learn more

Smoldering Myeloma
Monoclonal Gammopathy of Undetermined Significance (MGUS)

Resources